New ASAP Long-Term Findings Reveal: Disease Risk, Not Remission Status, Drives Transplant Outcomes in Acute Myeloid Leukemia (AML)
The ASAP Trial Redefines Treatment Paradigms for Acute Myeloid Leukemia: High-Dose Chemotherapy May Not Be Essential Before Stem Cell Transplantation ...
